| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72162-2213-2 | 72162-2213 | HUMAN PRESCRIPTION DRUG | MESALAMINE | mesalamine | TABLET, DELAYED RELEASE | ORAL | 20240529 | N/A | ANDA | ANDA217337 | Bryant Ranch Prepack | MESALAMINE | 1.2 g/1 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (72162-2213-2) |
| 0527-3012-48 | 0527-3012 | HUMAN PRESCRIPTION DRUG | MESALAMINE | mesalamine | TABLET, DELAYED RELEASE | ORAL | 20230603 | N/A | ANDA | ANDA217337 | Lannett Company Inc. | MESALAMINE | 1.2 g/1 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (0527-3012-48) |
| 62135-714-60 | 62135-714 | HUMAN PRESCRIPTION DRUG | Mesalamine | Mesalamine | TABLET, DELAYED RELEASE | ORAL | 20230721 | N/A | ANDA | ANDA217337 | Chartwell RX, LLC | MESALAMINE | 1.2 g/1 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (62135-714-60) |
| 62135-714-12 | 62135-714 | HUMAN PRESCRIPTION DRUG | Mesalamine | Mesalamine | TABLET, DELAYED RELEASE | ORAL | 20230721 | N/A | ANDA | ANDA217337 | Chartwell RX, LLC | MESALAMINE | 1.2 g/1 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (62135-714-12) |